ContraFect Prices Public Offering

- July 20th, 2017

ContraFect priced its upcoming public offering of common stock and warrants at $40 million.

ContraFect (NASDAQ:CFRX) priced its upcoming public offering of common stock and warrants at $40 million.
As quoted in the press release:

The pricing of its underwritten public offering of 32,000,000 shares of its common stock and related warrants to purchase 16,000,000 shares of common stock with an exercise price of $1.55 per share at a combined public offering price of $1.25 per share and related warrant. All shares and warrants in the offering are to be sold by ContraFect. The gross proceeds from the offering will be $40.0 million.
The offering is expected to close on or about July 25, 2017, subject to customary closing conditions.

Click here to read the full press release.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply

Your email address will not be published. Required fields are marked *